Autoimmune haemolytic anaemia emerging during Campath treatment in a patient with CD5 negative chronic lymphocytic leukaemia

作者：Ames Paul R J^*; Aw Darren; Rainey Mervin G

来源：Indian Journal of Hematology and Blood Transfusion, 2014, 30(S1): S43-S45.

DOI：10.1007/s12288-013-0239-2

• Campath
• CMV
• Haemolytic anemia
• Lymphoid leukaemia

Campath is being employed for the treatment of autoimmune haemolytic anemia (AIHA) whether or not associated to B cell chronic lymphoid leukaemia (CLL). CD5 negative CLL is relatively uncommon and runs an indolent course. We report a CD5 negative CLL patient who developed AIHA associated with cytomegalovirus infection reactivation whilst on treatment with Campath for progressive disease.

• 出版日期2014-9